“Prophylactic Intravenous Ketorolac for Prevention of Intraventricular Hemorrhage in Preterm Infants < 32 Weeks and < 1500 Grams: A Double-Blind, Randomized, Placebo-Controlled Trial”, Acta Med Philipp, vol. 50, no. 2, Jun. 2016, doi: 10.47895/amp.v50i2.847.